focus -WSS

focus

author：comprehensive 2025-09-30 01:01:36 - browse：7

Venture firms backing health tech startups are telegraphing cautious optimism for 2024, advising startups to expect smaller and fewer checks as well as possible market consolidation but not to abandon hope just yet as investments stabilize following a sharp drop-off.

As customers — often health systems, payers, or employers — and backers plot how they’ll invest shrinking budgets, they’re increasingly savvy about metrics, investors told STAT. They’re also less interested in rapid growth, and more keen on startups that can demonstrate savings and efficiency.

That’s a sharp contrast from the unrestrained health tech investments that peaked in 2021, fueled by a pandemic-era frenzy for virtual appointments, mental health care and app-based therapies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Wegovy leads to weight loss. Can it treat depression, too?

WSS

Investment in vaccine development is lagging, report finds

Health Care Service Corp to buy Cigna Medicare Advantage plans

Boston competes with Raleigh

Reconstructing family trees of blood cells may help predict disease

American TikTok star stuck in Dubai for months following rental car altercation

Merck, Johnson & Johnson CEOs will testify on high drug prices

Wikipedia

focus

hotspot

In age of alternative facts, a scholarly course on calling out crap

Snowpack in the West is melting rapidly. Where will all that extra water go?

Medicare details structure of new drug price negotiation program

FTC sues over Novant Health acquisition of two N.C. hospitals

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Bright Health sells Medicare Advantage business to Molina

Philips to halt sales of sleep apnea machines in U.S.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

focus

Bernie Sanders is gearing up to subpoena pharma CEOs

Vertex non

Investment in vaccine development is lagging, report finds

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Doctors increasingly discourage vaping amid mounting health concerns

Merck CEO won’t testify in Senate, citing no expertise in drug prices

hotspot

explore

explore

focus